243: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection

George Scangos, the CEO of Vir Biotechnology, joins us to discuss his retirement and offer some perspective and lessons from a remarkable, 40-year career in biotech. We also chat about the latest news in the life sciences, including an FDA advisory meeting debating the necessity for annual Covid vaccinations, and a surprising, but perhaps not, rejection of Eli Lilly’s Alzheimer’s disease treatment.

Episode metadata supplied by the publisher feed · Published Jan 26, 2023

Embed this episode

Attribution link and audio player

Ready to play

243: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection

0:00 31:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 31 minutes long.

When was this The Readout Loud episode published?

This episode was published on January 26, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!